Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MUVON Therapeutics
company
About
Muvon Therapeutics is a biotech company developing autologous cell therapies to restore skeletal muscle.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Muvon Therapeutics platform helps women with urinary incontinence and treats diseases based on skeletal muscle degradation, supporting them in their commitment to living a healthy life. The company's mode of contact is by mail, phone, and physical address.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
MUVON Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
May 31, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2021 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
MUVON Therapeutics is funded by 1 investors.
Lichtsteiner Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lichtsteiner Foundation
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
